CHAPTER 1 INTRODUCTION

1.1. KEY BENEFITS
1.2. KEY MARKET SEGMENTS
1.3. KEY PLAYERS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top winning strategies
3.2.2. Top investment pockets
3.2.3. Market Share Analysis, 2016

3.3. MARKET DYNAMICS

3.3.1. Drivers

3.3.1.1. Growing incidence of cardiovascular diseases
3.3.1.2. Technological advancements
3.3.1.3. Rising awareness regarding public access defibrillators (PADs)
3.3.1.4. High presence of unmet medical needs especially in untapped economies

3.3.2. Restraints

3.3.2.1. Lack of awareness regarding sudden cardiac arrest (SCA) and device availability
3.3.2.2. Safety concerns related to automated external defibrillators
3.3.2.3. Limited insurance coverage and high cost of defibrillators

3.3.3. Opportunities

3.3.3.1. Lucrative opportunities in emerging economies
3.3.3.2. Favorable government initiatives for the adoption of AEDs at public places

CHAPTER 4 EXTERNAL DEFIBRILLATORS MARKET, BY PRODUCT TYPE

4.1. OVERVIEW

4.1.1. Key market trends
4.1.2. Growth factors and opportunities
4.1.3. Market size and forecast

4.2. MANUAL EXTERNAL DEFIBRILLATOR

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. AUTOMATED EXTERNAL DEFIBRILLATOR (AED)

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast By Type
4.3.4. Market size and forecast By Geography

4.4. WEARABLE CARDIOVERTER DEFIBRILLATOR (WCD)

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

CHAPTER 5 EXTERNAL DEFIBRILLATORS MARKET, BY END USER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. HOSPITALS

5.2.1. Market size and forecast

5.3. PREHOSPITALS

5.3.1. Market size and forecast

5.4. PUBLIC ACCESS MARKETS

5.4.1. Market size and forecast

5.5. ALTERNATIVE CARE MARKET

5.5.1. Market size and forecast

5.6. HOME

5.6.1. Market size and forecast

CHAPTER 6 EXTERNAL DEFIBRILLATORS MARKET, BY REGION

6.1. OVERVIEW

6.1.1. Market size and forecast by Region
6.1.2. Market size and forecast by Product
6.1.3. Market size and forecast by End User

6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Growth factors and opportunities
6.2.3. Market size and forecast by Country
6.2.4. Market size and forecast by Product
6.2.5. Market size and forecast by End User

6.2.5.1. U.S. market size and forecast
6.2.5.2. Canada market size and forecast
6.2.5.3. Mexico market size and forecast

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Growth factors and opportunities
6.3.3. Market size and forecast by Country
6.3.4. Market size and forecast by Product
6.3.5. Market size and forecast by End User

6.3.5.1. UK market size and forecast
6.3.5.2. Germany market size and forecast
6.3.5.3. France market size and forecast
6.3.5.4. Italy market size and forecast
6.3.5.5. Spain market size and forecast
6.3.5.6. Rest of Europe market size and forecast

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Growth factors and opportunities
6.4.3. Market size and forecast by Country
6.4.4. Market size and forecast by Product
6.4.5. Market size and forecast by End User

6.4.5.1. Japan market size and forecast
6.4.5.2. China market size and forecast
6.4.5.3. India market size and forecast
6.4.5.4. Australia market size and forecast
6.4.5.5. Rest of Asia-Pacific market size and forecast

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Growth factors and opportunities
6.5.3. Market size and forecast by Country
6.5.4. Market size and forecast by Product
6.5.5. Market size and forecast by End User

6.5.5.1. Brazil market size and forecast
6.5.5.2. Argentina market size and forecast
6.5.5.3. Egypt market size and forecast
6.5.5.4. Israel market size and forecast
6.5.5.5. South Africa market size and forecast
6.5.5.6. Rest of LAMEA market size and forecast

CHAPTER 7 COMPANY PROFILES

7.1. NIHON KOHDEN CORPORATION

7.1.1. Company overview
7.1.2. Operating business segments
7.1.3. Business performance
7.1.4. Key strategic moves and developments

7.2. CARDIAC SCIENCE CORPORATION

7.2.1. Company overview
7.2.2. Operating business segments
7.2.3. Business performance
7.2.4. Key strategic moves and developments

7.3. KONINKLIJKE PHILIPS N.V. (PHILIPS HEALTHCARE)

7.3.1. Company overview
7.3.2. Operating business segments
7.3.3. Business performance
7.3.4. Key strategic moves and developments

7.4. HEARTSINE TECHNOLOGIES LLC.

7.4.1. Company overview
7.4.2. Operating business segments
7.4.3. Business performance
7.4.4. Key strategic moves and developments

7.5. ZOLL MEDICAL CORPORATION

7.5.1. Company overview
7.5.2. Operating business segments
7.5.3. Business performance
7.5.4. Key strategic moves and developments

7.6. MINDRAY MEDICAL INTERNATIONAL LIMITED

7.6.1. Company overview
7.6.2. Operating business segments
7.6.3. Business performance
7.6.4. Key strategic moves and developments

7.7. DEFIBTECH, LLC

7.7.1. Company overview
7.7.2. Operating business segments
7.7.3. Business performance
7.7.4. Key strategic moves and developments

7.8. PHYSIO-CONTROL, INC.

7.8.1. Company overview
7.8.2. Operating business segments
7.8.3. Business performance
7.8.4. Key strategic moves and developments

7.9. GENERAL ELECTRIC COMPANY (GE HEALTHCARE)

7.9.1. Company overview
7.9.2. Operating business segments
7.9.3. Business performance
7.9.4. Key strategic moves and developments

7.10. SCHILLER AG

7.10.1. Company overview
7.10.2. Operating business segments
7.10.3. Business performance
7.10.4. Key strategic moves and developments